<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03683836</url>
  </required_header>
  <id_info>
    <org_study_id>T125/2016</org_study_id>
    <nct_id>NCT03683836</nct_id>
  </id_info>
  <brief_title>Minor Troponin Elevations in Patients With Atrial Fibrillation</brief_title>
  <acronym>Tropo-AF</acronym>
  <official_title>Etiology of Minor Troponin Elevations in Patients With Atrial Fibrillation Visiting Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Turku</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at identifying the etiology of troponin-T elevations in patients with atrial
      fibrillation visiting the emergency department.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to identify the factors associated with minor cardiac troponin-T
      elevations in patients presenting in emergency department (ED) with atrial fibrillation (AF)
      diagnosis , and the possible implications it has on the patients prognosis. Data on 3394
      patients from the Turku university hospital catchment area with diagnosis of AF on admission
      to ED and minor troponin-T elevation were analyzed. Patients were classified into three
      groups according to the troponin-T value: troponin &lt;15ng/l, 15-50ng/l and 51-100ng/l.
      Individual patient records were reviewed.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 1, 2016</start_date>
  <completion_date type="Anticipated">October 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause mortality, myocardial infarction, ischemic stroke</measure>
    <time_frame>12 months</time_frame>
    <description>Major adverse cardiac or cerebrovascular event within one year</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3394</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Myocardial Ischemia</condition>
  <arm_group>
    <arm_group_label>Study Group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with atrial fibrillation admitted to Turku University Hospital emergency
        department
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  two troponin T tests within 72 hours of ED admission

          -  Prior diagnosis of AF or AF at admission

        Exclusion Criteria:

          -  Age &lt; 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>September 22, 2018</study_first_submitted>
  <study_first_submitted_qc>September 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2018</study_first_posted>
  <last_update_submitted>August 17, 2019</last_update_submitted>
  <last_update_submitted_qc>August 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Turku University Hospital</investigator_affiliation>
    <investigator_full_name>Juhani Airaksinen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

